These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23925270)

  • 1. Susceptibility-weighted MR imaging in the grading of liver fibrosis: a feasibility study.
    Balassy C; Feier D; Peck-Radosavljevic M; Wrba F; Witoszynskyj S; Kiefer B; Reiter G; Dai Y; Ba-Ssalamah A
    Radiology; 2014 Jan; 270(1):149-58. PubMed ID: 23925270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of fibrotic liver disease with whole-liver T1ρ MR imaging: a feasibility study at 1.5 T.
    Allkemper T; Sagmeister F; Cicinnati V; Beckebaum S; Kooijman H; Kanthak C; Stehling C; Heindel W
    Radiology; 2014 May; 271(2):408-15. PubMed ID: 24475807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index.
    Huwart L; Sempoux C; Salameh N; Jamart J; Annet L; Sinkus R; Peeters F; ter Beek LC; Horsmans Y; Van Beers BE
    Radiology; 2007 Nov; 245(2):458-66. PubMed ID: 17940304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
    Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis and postoperative fistula of the pancreas: correlation with MR imaging findings--preliminary results.
    Watanabe H; Kanematsu M; Tanaka K; Osada S; Tomita H; Hara A; Goshima S; Kondo H; Kawada H; Noda Y; Tanahashi Y; Kawai N; Yoshida K; Moriyama N
    Radiology; 2014 Mar; 270(3):791-9. PubMed ID: 24475834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging.
    Feier D; Balassy C; Bastati N; Stift J; Badea R; Ba-Ssalamah A
    Radiology; 2013 Nov; 269(2):460-8. PubMed ID: 23878281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.
    Bastati N; Feier D; Wibmer A; Traussnigg S; Balassy C; Tamandl D; Einspieler H; Wrba F; Trauner M; Herold C; Ba-Ssalamah A
    Radiology; 2014 Jun; 271(3):739-47. PubMed ID: 24576046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.
    Aguirre DA; Behling CA; Alpert E; Hassanein TI; Sirlin CB
    Radiology; 2006 May; 239(2):425-37. PubMed ID: 16641352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.
    Lupşor M; Badea R; Stefănescu H; Grigorescu M; Sparchez Z; Serban A; Branda H; Iancu S; Maniu A
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):155-63. PubMed ID: 18568136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography.
    Asbach P; Klatt D; Schlosser B; Biermer M; Muche M; Rieger A; Loddenkemper C; Somasundaram R; Berg T; Hamm B; Braun J; Sack I
    Radiology; 2010 Oct; 257(1):80-6. PubMed ID: 20679447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis.
    Ou HY; Bonekamp S; Bonekamp D; Corona-Villalobos CP; Torbenson MS; Geiger B; Kamel IR
    AJR Am J Roentgenol; 2013 Oct; 201(4):W596-602. PubMed ID: 24059398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.
    Hagiwara M; Rusinek H; Lee VS; Losada M; Bannan MA; Krinsky GA; Taouli B
    Radiology; 2008 Mar; 246(3):926-34. PubMed ID: 18195377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive evaluation of hepatic fibrosis in hepatitis C virus-infected patients using ethoxybenzyl-magnetic resonance imaging.
    Nojiri S; Kusakabe A; Fujiwara K; Shinkai N; Matsuura K; Iio E; Miyaki T; Joh T
    J Gastroenterol Hepatol; 2013 Jun; 28(6):1032-9. PubMed ID: 23432660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience.
    Qayyum A; Goh JS; Kakar S; Yeh BM; Merriman RB; Coakley FV
    Radiology; 2005 Nov; 237(2):507-11. PubMed ID: 16244259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and staging.
    Mitchell DG; Navarro VJ; Herrine SK; Bergin D; Parker L; Frangos A; McCue P; Rubin R
    Abdom Imaging; 2008; 33(1):58-64. PubMed ID: 17387539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings.
    Kim SH; Lee JM; Han JK; Lee JY; Lee KH; Han CJ; Jo JY; Yi NJ; Suh KS; Shin KS; Jo SY; Choi BI
    Radiology; 2006 Jul; 240(1):116-29. PubMed ID: 16684918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.